We are live on ! Find out more
VANIW

Vivani Medical, Inc. Warrants expiring 03/14/2024
VANIW

Delisted

VANIW was delisted on the 8th of September, 2022.

Back to rankings

3 hedge funds and large institutions have $9K invested in Vivani Medical, Inc. Warrants expiring 03/14/2024 in 2022 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% less funds holding

Funds holding: 4 → 3 (-1)

59% less capital invested

Capital invested by funds: $22K → $9K (-$13K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$828

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$14K
Name Holding Trade Value Shares
Change 		Change in
Stake
SPC
1
Sigma Planning Corp
Michigan
$5K – – –
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$4K +$828 +3,161 +27%
Goldman Sachs
3
Goldman Sachs
New York
– -$14K -54,247 Closed

VANIW Hedge Fund Activity: Q1 2022 in Review

3 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical, Inc. Warrants expiring 03/14/2024 (VANIW) for Q1 2022, worth a combined $9K — down 59% from $22K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of VANIW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was Susquehanna International Group, adding an estimated $828. The largest seller was Goldman Sachs, exiting entirely with an estimated $14K sold.

  • 3 institutional investors held Vivani Medical, Inc. Warrants expiring 03/14/2024 (VANIW) as of Q1 2022, down from 4 in Q4 2021.
  • Funds reported $9K of Vivani Medical, Inc. Warrants expiring 03/14/2024 stock for Q1 2022, down 59% quarter-over-quarter.
  • 0 funds opened new Vivani Medical, Inc. Warrants expiring 03/14/2024 positions in Q1 2022 and 1 closed out, a net change of -1 holder.
  • The largest Vivani Medical, Inc. Warrants expiring 03/14/2024 buyer in Q1 2022 was Susquehanna International Group, an estimated $828 added.
  • The largest Vivani Medical, Inc. Warrants expiring 03/14/2024 seller in Q1 2022 was Goldman Sachs, an estimated $14K sold.

Based on aggregated 13F filings for Q1 2022.